Ultrasonic Debridement with Stem Cell Therapy of Suspensory Branch Desmitis in an Equine Patient

Volume 2 - Issue 2

Srinath Kamineni MD*, Alan Ruggles and Hamza Ashfaq

Received: January 13, 2019;   Published: January 31, 2019

DOI: 10.32474/CDVS.2018.02.000135

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Ultrasonic debridement as a treatment for tendinopathy and desmitis is a relatively new approach in orthopedic surgery. Previously only used in limited cases, this procedure shows promise for treating ligament-bone and tendon-bone interface injuries. We present a case study of a 2-year-old thoroughbred male horse, unable to train due to recalcitrant symptoms after extensive conservative management of suspensory branch desmitis (SBD). He was then treated with ultrasonic debridement and concurrent manubrial stem cell autograft injection, to treat the ultrasound visualized lesion. Post-surgically the patient recovered quickly, began training within 6 weeks and went onto win several races. Repeat ultrasound imaging reveals a complete restoration of the internal fiber architecture of the ligament. With a 3 year follow-up, there has been consistent training and race performance with no re-injury. This study is the first to document the successful outcome of ultrasonic debridement with concurrent stem cell injection in the treatment of equine desmitis.

Keywords:Suspensory branch ligament; Desmitis; Ultrasonic Debridement; Equine; Orthopedics

Abstract| Introduction| Case Details| Discussion| References|